The rise in Venus Remedies share price came after the company announced the renewal of its European GMP certification by ...

The biotech market offers great investment potential due to innovative advancements in genetic profiling, biologics, CRISPR ...

MHRA’s independence also questioned during Commons debate, with regulator accused of being too close to companies it ...

Pharma major Venus Remedies on Tuesday said it has secured renewal of European Good Manufacturing Practices (EU-GMP) certification by Infarmed, the National Authority of Medicines and Health Products ...

Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and genetic testing, today announced that its CEO, Steve ...

We recently published a list of the 12 Biotech Stocks with the Biggest Upside Potential. In this article, we are going to take a look at where Ultragenyx Pharmaceutical, Inc.

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They ...

Amgen's dividend profile shines, but growth slows. See why AMGN stock faces regulatory risks and offers limited incentives ...

We recently compiled a list of the 10 Under-the-Radar Stocks with Massive Upside for 2025. In this article, we are going to ...

West Pharmaceutical Services, Inc. WST is well poised for growth, backed by the robust Proprietary Products segment and ...

SpringWorks Therapeutics Inc . (NASDAQ:SWTX), a biotechnology company with a market capitalization of $2.66 billion focused ...

CollaMedix, a Cleveland-based medical device company, is poised for growth in 2025 following its recent move to a much larger ...